Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Mater Children's Hospital in Australia Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities

February 21, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif. and BRISBANE, Australia, Feb. 21, 2011 /- Mater Children's Hospital and Masimo (Nasdaq: MASI ) today jointly announce the conversion of Mater Children's Hospital to Masimo rainbow® SET Pulse CO-Oximetry™ technology for advanced noninvasive patient monitoring...

A Presidential Pardon on Joint Pain

February 21, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

BRADENTON, Fla., Feb. 21, 2011 /- Past presidents such as Gerald Ford, Ronald Reagan, and George H.W. Bush are among the millions of Americans who have undergone some form of joint replacement/repair surgery. While we see presidents come and go, advancements in joint replacement...

Sheffield Bio-Science and Wockhardt Announce Worldwide Exclusive Partnership to Supply Recombinant Insulin to Cell Culture Market

February 21, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

BELOIT, Wis., Feb. 21, 2011 /- Sheffield Bio-Science, a Kerry Group Business, has formed a strategic global sales, marketing and development alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the Exclusive Global Sales and Distribution Partner for...

Advertisement

LifeWatch Teams With UnitedHealthcare, The Largest Healthcare Insurer In The United States, As A Preferred National Provider Of Cardiac Monitoring Services To Reduce Patient C...

February 20, 2011 10:34 pm | by Bio-Medicine.Org | News | Comments

ROSEMONT, Ill., Feb. 21, 2011 /- LifeWatch AG (SIX Swiss Exchange: LIFE) today announces an initiative with UnitedHealthcare Insurance Company, an affiliate of United-Health Group (NYSE: UNH) that will provide members insured by UnitedHealthcare in-network access to LifeWatch cardiac...

Increasing triglyceride levels linked to greater stroke risk

February 20, 2011 8:34 pm | by EurekAlert | News | Comments

(Wiley-Blackwell) A study by researchers in Denmark revealed that increasing levels of non-fasting triglycerides are associated with an increased risk of ischemic stroke in men and women. Higher cholesterol levels were associated with greater stroke risk in men only. Details of this...

New NxStage® FREEDOM Data Shows Continued, Marked Benefits for Patients Using the System One™ for Daily Home Hemodialysis Throughout a 12 Month Period(2)

February 20, 2011 6:35 pm | by Bio-Medicine.Org | News | Comments

LAWRENCE, Mass. and PHOENIX, Feb. 20, 2011 /- NxStage® Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM study which show an increase in overall quality of life benefits,...

One Health: From ideas to implementation, rhetoric to reality

February 20, 2011 9:33 am | by EurekAlert | News | Comments

(American Society for Microbiology) The convergence of people, animals, and our environment has created a new dynamic in which the health of each group is inextricably and globally interconnected, without borders. It is against this background that One Health has emerged as a...

CompanDX Ltd. and Clinical Reference Laboratory, Inc. Sign Multi-Year Deal in Support of Collaborative Gene Signature and Companion Diagnostic Development

February 19, 2011 3:31 am | by Bio-Medicine.Org | News | Comments

LENEXA, Kan., Feb. 19, 2011 /- CompanDX Ltd., bioinformatics partner for the life sciences industry, and Clinical Reference Laboratory, Inc. (CRL), provider of laboratory testing services in molecular diagnostics and clinical trials, today announced they entered into a multi-year...

Advertisement

FDA Down-Classifies MDDS to Class I Via Final Rule

February 18, 2011 7:30 pm | by U.S. Food & Drug Administration | News | Comments

The FDA has down-classified medical device data systems (MDDS) from Class III into Class I via a final rule, which could help manufacturers compete with IT companies in this area.

FDA Questions UK Regulator & #8217;s Data on Hip Implant Recalls(2)

February 18, 2011 5:31 pm | by U.S. Food & Drug Administration | News | Comments

Quality problems with metal-on-metal (MoM) hip replacement systems, like Johnson & Johnson (J&J)’s ASR devices, may not be as widespread as UK data indicates, the FDA says.

Saint Louis U Scientists Partner on Malaria Research

February 18, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Feb. 18, 2011 /PRNewswire-USNewswire/ --  The Center for World Health & Medicine at Saint Louis University and China's Guangzhou Institutes of Biomedicine and Health (GIBH) are forming a global research partnership that initially will focus on new treatments for...

Grifols Starts Construction of a New Plasma Fractionation Plant in Barcelona (Parets Del Valles)

February 18, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

BARCELONA, Spain, Feb. 18, 2011 /- Grifols, the Spanish group which specializes in the hospital-pharmaceutical sector and is one of the world's leading producers of plasma products, will shortly start construction of a new plant representing an investment of 20 million euros that will...

Smith & Nephew's Exclusive OXINIUMâ„¢ Material for Hip Replacement Implants Chosen for Premium Reimbursement in Japanese Market

February 18, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

MEMPHIS, Tenn., Feb. 18, 2011 /- OXINIUM™ Oxidized Zirconium, the patented advanced bearing material from Smith & Nephew (NYSE: SNN, LSE: SN) Orthopaedics Division, has been awarded a C1 premium reimbursement classification in Japan for use in hip replacement surgery. The...

Advertisement

NACDS, NCPA Provide Insights to Governors and State Medicaid Directors Confronting Medicaid Budgetary Challenges

February 18, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

ALEXANDRIA, Va., Feb. 18, 2011 /PRNewswire-USNewswire/ -- The National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association (NCPA) have sent a joint letter to every Governor and State Medicaid Director, explaining the importance of pharmacies in...

Smith & Nephew Enables Minimally Invasive and Anterior Approach Hip Replacement Surgeries With Launch of Modular, Mini Hip Stem

February 18, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

MEMPHIS, Tenn., Feb. 18, 2011 /- At this week's annual meeting of the American Academy of Orthopedic Surgeons, Smith & Nephew (NYSE: SNN, LSE: SN) Orthopaedic Division introduced its Short Modular Femoral (SMF™) Hip System, a modular total hip replacement stem system that...

Penn Doctors Certified in New Advanced Heart Failure and Transplant Cardiology Specialty

February 18, 2011 6:33 am | by University Of Pennsylvania | News | Comments

Penn Medicine cardiologists are leaders in a new cardiology subspecialty, Advanced Heart Failure and Transplant Cardiology. Seven of the nine Heart Failure and Transplant doctors at Penn are now certified by the American Board of Internal Medicine (ABIM) in the new Advanced Heart Failure...

American Scientific Resources Announces New Distributor HospiServices Placing Kidz-Med VeraTemp in Middle Eastern and African Pharmacies

February 18, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

WESTON, Fla., Feb. 18, 2011 /- American Scientific Resources, Inc. (Pink Sheets: ASFX ) announces Lebanon-based HospiServices is the Company's new distributor in the Middle East and Africa. HospiServices has placed its second order totaling 684 units for the Kidz-Med line of VeraTemp...

Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call

February 18, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

CARY, N.C., Feb. 18, 2011 /- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ) today announced that it will host a conference call at 8:30 AM ET on Thursday, March 3, 2011, to discuss its financial results for the quarter and twelve months ended December 31, 2010. Financial results are...

Two Knee Replacements May Be Better Than One

February 18, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Feb. 18, 2011 /PRNewswire-USNewswire/ -- Replacing both knees in one surgery, or simultaneous total knee replacement (TKR) was associated with significantly fewer prosthetic joint infections as well as other revision knee operations within one year after surgery, compared with...

Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe

February 18, 2011 3:38 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Feb. 18, 2011 /- Life Technologies Corporation (Nasdaq: LIFE ), today announced Dr. Angel Carracedo and Dr. Mark Pallen as the winners of the European Ion Torrent Personal Genome Machine (PGM™) Sequencer Grants Program.   (Logo:  ...

Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine

February 18, 2011 3:38 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla., Feb. 18, 2011 /- Bellicum Pharmaceuticals, Inc. today announced the presentation of Phase I/II safety and efficacy data for BPX-101, a novel drug-activated dendritic cell vaccine for metastatic castrate resistant prostate cancer (mCRPC), in three separate posters at the...

NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting

February 18, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Feb. 18, 2011 /- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage biopharmaceutical company, today presented the final safety and immunogenicity results from its 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine clinical trial in Mexico at the invitation-only 7th...

Zimmer Announces Early Clinical Success of Zimmer® MotionLoc™ Screw Implantation

February 18, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Feb. 18, 2011 /- Zimmer Holdings, Inc. (NYSE: ZMH ; SIX: ZMH), a global leader in musculoskeletal care, today announced that early clinical results of the first patients treated with Zimmer MotionLoc™ Screws were free of complications.  The Zimmer MotionLoc Screw is...

Zimmer Spine Introduces Industry's First Porous Metal Cervical Interbody Device

February 18, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Feb. 18, 2011 /- Zimmer Holdings, Inc. (NYSE: ZMH ; SIX: ZMH), a leader in musculoskeletal care, today announced it has received FDA clearance for the TM-S Trabecular Metal™ Cervical Interbody Fusion Device.  The TM-S system is the industry's first cervical interbody...

Boston Scientific Launches PROMUS® Elementâ„¢ and TAXUS® Elementâ„¢ Stent Systems in India

February 18, 2011 3:36 am | by Boston Scientific | News | Comments

Company's third-generation drug-eluting stents now available in rapidly growing market

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading